Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infections

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 12, 2010, Pages 5161-5166

  San Juan, Rafael ^a   Garcia Reyne, Ana ^a   Caba, Pedro ^a   Chaves, Fernando ^a   Resines, Carlos ^a   Llanos, Fernando ^a   López Medrano, Francisco ^a   Lizasoain, Manuel ^a   Aguado, Jose Maria ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CEFAZOLIN; CLOXACILLIN; MOXIFLOXACIN; VANCOMYCIN;

ADULT; ARTICLE; BONE RADIOGRAPHY; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HUMAN; JOINT PROSTHESIS; MALE; MONOTHERAPY; ORTHOPEDIC PROSTHESIS; OSTEOSYNTHESIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; RELAPSE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; QUINOLINES; STAPHYLOCOCCAL INFECTIONS;

EID: 78649644442     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00027-10     Document Type: Article

References (28)

1. Bahl, D., D. A. Miller, I. Leviton, P. Gialanella, M. J. Wolin, W. Liu, R. Perkins, and M. H. Miller. 1997. In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 41:1293-1297.
2. Barberan, J., L. Aguilar, G. Carroquino, M. J. Gimenez, B. Sanchez, D. Martinez, and J. Prieto. 2006. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am. J. Med. 119:993.e7-e10.
3. Barberan, J., L. Aguilar, M. J. Gimenez, G. Carroquino, J. J. Granizo, and J. Prieto. 2008. Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation. Int. J. Antimicrob. Agents 32:154-157.
4. Bogdanovich, T., D. Esel, L. M. Kelly, B. Bozdogan, K. Credito, G. Lin, K. Smith, L. M. Ednie, D. B. Hoellman, and P. C. Appelbaum. 2005. Anti-taphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents. Antimicrob. Agents Chemother. 49:3325-3333.
5. Brandt, C. M., M. C. Duffy, E. F. Berbari, A. D. Hanssen, J. M. Steckelberg, and D. R. Osmon. 1999. Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin. Proc. 74:553-558.
6. Callaghan, J. J., R. P. Katz, and R. C. Johnston. 1999. One-stage revision surgery of the infected hip. A minimum 10-year followup study. Clin. Orthop. Relat. Res. 369:139-143.
7. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing, 17th informational supplement: M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Del Pozo, J. L., and R. Patel. 2009. Clinical practice. Infection associated with prosthetic joints. N. Engl. J. Med. 361:787-794.
9. Frank, K. L., E. J. Reichert, K. E. Piper, and R. Patel. 2007. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob. Agents Chemother. 51:888-895.
10. Hope, P. G., K. G. Kristinsson, P. Norman, and R. A. Elson. 1989. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J. Bone Joint Surg. Br. 71:851-855.
11. Kalteis, T., J. Beckmann, H. J. Schroder, M. Handel, J. Grifka, N. Lehn, and K. Lerch. 2006. Moxifloxacin superior to vancomycin for treatment of bone infections - a study in rats. Acta Orthop. 77:315-319.
12. Kalteis, T., J. Beckmann, H. J. Schroder, J. Schaumburger, H. J. Linde, K. Lerch, and N. Lehn. 2006. Treatment of implant-associated infections with moxifloxacin: an animal study. Int. J. Antimicrob. Agents 15:15.
13. Murillo, O., A. Domenech, A. Garcia, F. Tubau, C. Cabellos, F. Gudiol, and J. Ariza. 2006. Efficacy of high doses of levofloxacin in experimental foreignbody infection by methicillin-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 50:4011-4017.
14. Murillo, O., M. E. Pachon, G. Euba, R. Verdaguer, F. Tubau, C. Cabellos, J. Cabo, F. Gudiol, and J. Ariza. 2008. Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection. Antimicrob. Agents Chemother. 52:3681-3686.
15. Perez-Giraldo, C., C. Gonzalez-Velasco, R. M. Sanchez-Silos, C. Hurtado, M. T. Blanco, and A. C. Gomez-Garcia. 2004. Moxifloxacin and biofilm production by coagulase-negative staphylococci. Chemotherapy 50:101-104.
16. Perlroth, J., M. Kuo, J. Tan, A. S. Bayer, and L. G. Miller. 2008. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature. Arch. Intern. Med. 168:805-819.
17. Raut, V. V., P. D. Siney, and B. M. Wroblewski. 1994. One-stage revision of infected total hip replacements with discharging sinuses. J. Bone Joint Surg. Br. 76:721-724.
18. Schwank, S., Z. Rajacic, W. Zimmerli, and J. Blaser. 1998. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob. Agents Chemother. 42:895-898.
19. Segawa, H., D. T. Tsukayama, R. F. Kyle, D. A. Becker, and R. B. Gustilo. 1999. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J. Bone Joint Surg. Am. 81:1434-1445.
20. Stengel, D., K. Bauwens, J. Sehouli, A. Ekkernkamp, and F. Porzsolt. 2001. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect. Dis. 1:175-188.
21. Ure, K. J., H. C. Amstutz, S. Nasser, and T. P. Schmalzried. 1998. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J. Bone Joint Surg. Am. 80:961-968.
22. Widmer, A. F., R. Frei, Z. Rajacic, and W. Zimmerli. 1990. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J. Infect. Dis. 162:96-102.
23. Windsor, R. E., J. N. Insall, W. K. Urs, D. V. Miller, and B. D. Brause. 1990. Two-stage reimplantation for the salvage of total knee arthroplasty complicated by infection. Further follow-up and refinement of indications. J. Bone Joint Surg. Am. 72:272-278.
24. Wroblewski, B. M. 1986. One-stage revision of infected cemented total hip arthroplasty. Clin. Orthop. Relat. Res. 211:103-107.
25. Zimmerli, W., R. Frei, A. F. Widmer, and Z. Rajacic. 1994. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J. Antimicrob. Chemother. 33:959-967.
26. Zimmerli, W., A. Trampuz, and P. E. Ochsner. 2004. Prosthetic-joint infections. N. Engl. J. Med. 351:1645-1654.
27. Zimmerli, W., A. F. Widmer, M. Blatter, R. Frei, and P. E. Ochsner. 1998. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 279:1537-1541.
28. Zych, G. A., and J. J. Hutson, Jr. 1995. Diagnosis and management of infection after tibial intramedullary nailing. Clin. Orthop. Relat. Res. 315:153-162.